Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson’s Disease
To investigate the effects of Lycium barbarum polysaccharide (LBP) on pathological symptoms and behavioral deficits in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease (PD) mouse model. The therapeutic effects of LBP were monitored with an Open field test, a Rotarod test and a Morris water maze test. We also investigated the mechanisms with qRT-PCR and Western blotting analyses. After a relatively short-term LBP treatment, the total distance and walking time of PD mice significantly increased. The staying duration on the rod of PD mice increased in the Rotarod test. LBP can up-regulate levels of SOD2, CAT and GPX1 and inhibit the abnormal aggregation of α-synuclein induced by MPTP. LBP treatment can also up-regulate the phosphorylation of AKT and mTOR, and may play its protective role by activating the PTEN/AKT/mTOR signaling axis. These results suggest that LBP can effectively alleviate the degeneration in the nigrostriatal system induced by MPTP treatment. It may be a potential candidate for the treatment of Parkinson’s disease.
KeywordsParkinson’s disease Lycium barbarum polysaccharide α-Synuclein PTEN/AKT/mTOR pathway Oxidative stress
This study was supported by the National Natural Science Foundation of China [No. 81501135], the Natural science fund for colleges and universities in Jiangsu Province [No. 15KJB310026], the The science and technology projects fund of Yangzhou City [No. YZ2015112]
- 3.Quinn JG, Coulson DT, Brockbank S, Beyer N, Ravid R, Hellemans J, Irvine GB, Johnston JA (2012) Alpha-Synuclein mRNA and soluble alpha-synuclein protein levels in post-mortem brain from patients with Parkinson’s disease, dementia with Lewy bodies, and Alzheimer’s disease. Brain Res 1459:71–80CrossRefPubMedGoogle Scholar
- 25.Wang HB, Li YX, Hao YJ, Wang TF, Lei Z, Wu Y, Zhao QP, Ang H, Ma L, Liu J, Zhao CJ, Jiang YX, Wang YR, Dai XY, Zhang WN, Sun T, Yu JQ (2013) Neuroprotective effects of LBP on brain ischemic reperfusion neurodegeneration. Eur Rev Med Pharmacol Sci 20:2760–2765Google Scholar